A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Condition:   Acromegaly Intervention:   Drug: CAM2029 (octreotide subcutaneous depot) Sponsor:   Camurus AB Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 14, 2019 Category: Research Source Type: clinical trials

A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Condition:   Acromegaly Interventions:   Drug: CAM2029 (octreotide subcutaneous depot);   Drug: Matching placebo Sponsor:   Camurus AB Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 2, 2019 Category: Research Source Type: clinical trials